Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | ifenprodil | 3689 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | ifenprodil | 3689 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | ifenprodil | 3689 | drug-path |
| Axon guidance | R-HSA-422475 | map04360 | ifenprodil | 3689 | drug-path |
| Tight junction | R-HSA-2134514 | map04530 | ifenprodil | 3689 | drug-path |
| Asthma | R-HSA-444620 | map05310 | ifenprodil | 3689 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | ifenprodil | 3689 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | ifenprodil | 3689 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | ifenprodil | 3689 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | ifenprodil | 3689 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | ifenprodil | 3689 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | ifenprodil | 3689 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | scopoletin | 5280460 | drug-path |
| Renal cell carcinoma | R-HSA-9794523 | map05211 | scopoletin | 5280460 | drug-path |
| Adherens junction | R-HSA-451386 | map04520 | scopoletin | 5280460 | drug-path |
| Bladder cancer | R-HSA-9700206 | map05219 | scopoletin | 5280460 | drug-path |
| Melanoma | Q9UHD0-PRO_0000015379 | map05218 | scopoletin | 5280460 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | scopoletin | 5280460 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | cefepime | 3035905 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | cefepime | 3035905 | drug-path |